-
National Reimbursement Drug List (NRDL) Negotiations Conclude with Lower Generic Drug Approval Rate
•
The National Reimbursement Drug List (NRDL) negotiations for the year have concluded, with less than 50% of the total 162 participating generic name drugs passing the expert review. This approval rate is a decrease compared to 74.2% in 2022 and 63.8% in 2023. The successful drugs included 117 varieties from…
-
Hunan Province Includes Fertility Treatments in Medical Insurance Coverage from October 2024
•
The Hunan Healthcare Security Administration has issued a notification to include specific assisted reproductive medical services within the payment scope of Basic Medical Insurance (BMI) and Work Injury Insurance Funds, effective from October 1, 2024, for a period of five years. Under this policy, a total of eight items, including…
-
AstraZeneca Faces Investigation in China Over Data Privacy and Unapproved Drugs
•
AstraZeneca (NASDAQ: AZN), a leading UK pharmaceutical company, is reportedly under the spotlight in Shenzhen, China, with an investigation involving five current and former employees, as per a report by Bloomberg. The probe is said to center on potential breaches of data privacy regulations and the unauthorized importation of drugs…
-
China Unveils 2024 Plan to Combat Fraud in Medical Insurance Funds
•
The National Healthcare Security Administration (NHSA) of China, in conjunction with the Supreme People’s Court, the Supreme People’s Procuratorate, the Ministry of Public Security, the Ministry of Finance, and the National Health Commission, has unveiled the “2024 Special Work Plan for the Rectification of Illegal and Non-compliant Issues Related to…
-
Chinese Authorities Launch Special Plan to Rectify Medical Insurance Fraud and Non-Compliance
•
The National Healthcare Security Administration (NHSA) of China, in collaboration with the Supreme People’s Court, Supreme People’s Procuratorate, Ministry of Public Security, Ministry of Finance, and National Health Commission, has jointly issued the “2024 Special Work Plan for the Rectification of Illegal and Non-compliant Issues Related to Medical Insurance Funds.”…
-
Hebei Province Proposes Measures for ‘Internet+’ Medical Services and Insurance Management
•
The Hebei provincial Healthcare Security Administration (HSA) bureau has released a draft set of Measures titled “Hebei ‘Internet+’ Medical Service, Medical Insurance Management Measures,” which are now in effect and open for public comment until March 31, 2024. The document outlines the process for Internet medical institutions conducting “Internet +”…
-
Hunan Province Hospitals Commit to Implementing Nationally Negotiated Drugs in Policy Seminar
•
A policy seminar under the auspices of the Hunan Healthcare Security Administration bureau convened in Changsha, the capital of Hunan province, with the objective of ensuring the implementation of newly nationally negotiated drugs included in the National Reimbursement Drug List (NRDL). The event resulted in a consensus among hospital leaders…
-
China Regulators Chart Steady Path for ‘Huiminbao’ Medical Insurance Schemes
•
The China Banking and Insurance Regulatory Commission (CBIRC) and National Healthcare Security Administration (NHSA) have issued a notification outlining measures to ensure a stable and orderly implementation of urban ‘Huiminbao’ commercial top-up medical insurance schemes. The notice is open for feedback from insurance companies and industry associations nationwide. The document…
-
China’s NHSA Aims to Balance Drug Prices with New Monitoring System by March 2024
•
The National Healthcare Security Administration (NHSA) has issued a notification aimed at fostering inter-provincial price fairness, integrity, transparency, and balance for drugs sharing the same generic names and manufacturers. The initiative involves a comprehensive review and inspection of drugs based on four criteria: generic name, manufacturer, dosage form, and specification.…
-
Guangxi HSA Expands Coverage for Assisted Reproductive Medical Services Under BMI
•
The Healthcare Security Administration (HSA) bureau of the Guangxi Zhuang Autonomous Region has announced a significant expansion in coverage for assisted reproductive medical services under the Basic Medical Insurance (BMI) and work-related injury insurance fund. This initiative aims to enhance access to essential reproductive health services for residents in the…
-
EU Chamber of Commerce in China Releases Position Paper, Addresses Pharma and Healthcare
•
The EU Chamber of Commerce in China has released its bi-annual “European Business in China Position Paper 2023/2024,” which compiles recommendations from over 1,700 member companies. The document aims to foster constructive dialogue between Europe and China, enhancing engagement between European firms and Chinese stakeholders for mutual benefit. The paper…
